Phytochemical, Antioxidant, and Cytotoxicity screenings of n-hexane extract from Blumea balsamifera L leaves
-
Published:2023-04-29
Issue:
Volume:
Page:1664-1668
-
ISSN:0974-360X
-
Container-title:Research Journal of Pharmacy and Technology
-
language:en
-
Short-container-title:RJPT
Author:
Rawati Siti1, Ginting Binawati2, Maulana Ilham2, Yahya Mustanir2, Saidi Nurdin2, Murniana Murniana2, Hasballah Kartini3
Affiliation:
1. Postgraduate Student, Magister of Chemistry, Universitas Syiah Kuala, Banda Aceh 23111, Indonesia. 2. Department of Chemistry, Universitas Syiah Kuala, Banda Aceh 23111, Indonesia. 3. Department of Pharmacology, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh 23111, Indonesia.
Abstract
The significance of phytomedicine in the field of medicine has encouraged researchers to investigate the potential medicinal properties of plants. Of which, phytoconstituents of Blumea balsamifera have been reported to possess multiple pharmacological benefits. Unfortunately, recent published reports only cover the essential oils of B. balsamifera, obtained from hydro-distillation. Hence, our research aimed to explore the bioactivities of B. balsamifera leaves extracted with n-hexane solvent through partitioning. Firstly, simplicial powder of B. balsamifera leaves was macerated using methanol, and followed by partitioning in a separating funnel with n-hexane solvent. The sample was assayed with 2,2-diphenyl-1-picrylhydrazyl (DPPH) and brine shrimp (Artemia salina) lethality test for antioxidant activity and cytotoxicity, respectively. Lastly, the phytochemical profile of the n-hexane extract was analyzed using gas chromatography – mass spectrometry (GC-MS). In the results, we found the n-hexane extract as a weak antioxidant (IC50=281.707ppm) and moderately cytotoxic agent (LC50=44.47ppm). GC chromatogram revealed the dominance of two phytoconstituents – borneol L (33.77%) and veridiflorol (22.57%), where both are known to have anticancer activities. In conclusion, bioactive and phytochemical screenings of n-hexane extract from Blumea balsamifera leaves suggested its anticancer potential. Future research involving purification of the phytocompound and investigation using cancer cell lines is encouraged.
Publisher
A and V Publications
Subject
Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference42 articles.
1. Li, X.; Chen, W.; Simal-Gandara, J.; Georgiev, M. I.; Li, H.; Hu, H.; Wu, X.; Efferth, T.; Wang, S., West meets east: open up a dialogue on phytomedicine. Chin Med 2021, 16 (1), 57. 2. Sharma, B.; Bagchi, A.; Bhutia, S.; Sarkar, B. R.; Pal, P., Formulation and evaluation of expectorant activity of poly herbal cough syrup from traditional medicinal plant extracts of North East India. Research Journal of Pharmacy and Technology 2022, 15 (3), 949-3. 3. Singh, V.; Sara, U. S.; Rizvi, A., Pharmacognostic evaluation and establishment of quality parameters of leaves of Prosopis cineraria. Research Journal of Pharmacy and Technology 2022, 15 (2), 621-7. 4. Bajes, H. R.; Oran, S. A.; Al-Dujaili, E. A. S., Investigating the anti-viral and anti-bacterial activities of Jordanian medicinal plants: A narrative review. Research Journal of Pharmacy and Technology 2022, 15 (2), 127-136. 5. Andalia, N.; Salim, M. N.; Saidi, N.; Ridhwan, M.; Iqhrammullah, M.; Balqis, U., Molecular Docking Reveals Phytoconstituents of the Methanol Extract from Muntingia calabura as Promising α-Glucosidase Inhibitors Muntingia calabura as Promising-Glucosidase Inhibitors. Karbala International Journal of Modern Science 2022, 8 (3), 330-338.
|
|